Antibody-drug conjugate development: challenges and opportunities
By selectively delivering highly potent APIs to cancer cells, they offer a range of improved patient outcomes, including reduced side effects and higher drug tolerability.
Veranova provides an extensive portfolio of generic APIs. Our products cover a wide range of therapeutic classes, such as anti-cancer, anti-addiction, psychiatric disorders, and pain management.
Our API offering is supported by our network of GMP-compliant commercial manufacturing facilities in Europe and North America, to meet your global product requirements.
Download API and Controlled Substance Product Guide